- London-based MintNeuro has raised $5 million in a funding spherical led by Odyssey Ventures.
- The Imperial Faculty London spinout develops specialised chips for neural implants and wearables.
- The funding will speed up commercialisation, develop shipments to improvement companions and strengthen its US presence.
MintNeuro has raised $5 million to scale its semiconductor platform for neural gadgets, addressing a {hardware} bottleneck that may sluggish the event of brain-computer interfaces (BCIs) and different medical applied sciences.
The spherical was led by Odyssey Ventures, with participation from JSK Investments, 33East and Alumni Ventures. Present buyers Empirical Ventures, Jumpspace Ventures and earlier backers additionally reinvested.
The funding will help product launches, supply of pre-production chips to companions, engineering enlargement and worldwide progress, significantly within the US. The corporate has already developed working silicon and reached integration milestones with Motif Neurotech and Amber Therapeutics.
Meet the founders behind MintNeuro
Based in 2022 as an Imperial Faculty London spinout, MintNeuro was co-founded by Dr Dorian Haci and Professor Tim Constandinou, constructing on analysis into next-generation neural interfaces. Haci is CEO, whereas Constandinou brings experience in bioelectronics and neural engineering.
The corporate is growing a modular semiconductor platform that mixes neural sensing, sign processing and electrical stimulation, serving to machine makers keep away from the expense and prolonged improvement cycles of designing customized chips.
“The principle impediment holding again neurotechnology in the present day just isn’t an absence of concepts, however {hardware}. MintNeuro is addressing this hole with a platform on which the complete business can construct. We have been satisfied to take a position by its sturdy expertise workforce, working chips and first long-term business contract,” mentioned Petra Cihlářová, Funding Director of the Enterprise Capital Sub-Fund at JSK Investments SICAV a.s.
The {hardware} behind next-generation neurotech
Neural gadgets may assist diagnose or deal with circumstances together with Parkinson’s illness, epilepsy, despair and listening to loss. Imperial College London notes that neurological circumstances have an effect on multiple billion individuals worldwide, highlighting the potential attain of applied sciences that interface straight with the nervous system.
Nonetheless, builders typically face a alternative between generic parts not designed to be used within the physique and costly, time-consuming customized chip improvement. MintNeuro goals to offer purpose-built, low-power chips that assist make neural gadgets smaller and speed up their development from analysis in direction of scientific use.
“We’re delighted to affix the JSK portfolio and achieve the backing of an investor with a robust community throughout Europe and the USA, the place we are actually increasing our operations. With its healthcare connections and expertise as each buyers and entrepreneurs, our partnership with JSK will assist us carry our chips nearer to the builders and clinicians shaping the way forward for neural gadgets,” mentioned Dorian Haci, Co-founder and CEO of MintNeuro.
The neurotechnology funding race
MintNeuro operates in a broader neurotechnology market attracting vital funding. Precision Neuroscience raised $250 million in Series D funding in September 2026, taking its whole funding to $430 million because it advances its minimally invasive brain-computer interface. Science Corporation raised $230 million in Sequence C funding in March 2026 to advance its retinal implant expertise and scientific trials.
Though these firms goal totally different functions, they illustrate investor curiosity within the {hardware} and interfaces wanted to attach expertise with the human nervous system.
“We see neurological circumstances affecting individuals even throughout their working lives. Neurotechnology has huge potential to rework the lives of hundreds of thousands of sufferers, however with out cutting-edge {hardware}, these improvements will stay within the laboratory. MintNeuro is constructing a necessary basis with out which the complete discipline can not transfer ahead,” added Simona Kijonková, Chair of the Board of Administrators and Chief Funding Officer of JSK Investments SICAV a.s.
With working chips, business partnerships and recent capital, MintNeuro is shifting in direction of its subsequent problem: turning specialised neural {hardware} right into a scalable platform for medical-device builders.